Nature Debuts Peer-Review Option

Authors submitting to Nature journals can soon request double-blind reviews.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, PETE O'SHEABeginning next month, authors submitting their work to Nature and its associated journals can request double-blind peer review, in which the authors’ names and affiliations will be withheld from reviewers (much like reviewers’ names and affiliations are currently withheld from the authors).

“Advocates of double-blind peer review suggest that it eliminates personal biases, such as those based on gender, seniority, reputation and affiliation,” Nature noted in its February 18 announcement.

In contrast, some researchers have advocated for open peer review, in which the authors and reviewers both are clearly identified, arguing that such increased transparency might further limit bias. But some open-peer-review advocates, such as PhD student Matthew Evans of the John Innes Centre in Norwich, U.K., suggest that, if reviews are to be blinded, double-blind is preferable to single-blind peer review.

“Good scientists will continue to publish good papers in good journals under a double-blind peer review system,” wrote Boyan Garvalov of Justus Liebig University Giessen, Germany, in a January Advances in Regenerative Biology article (hat ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery